Why Arhaus (ARHS) Shares Are Getting Obliterated Today What Happened: Shares of luxury furniture retailer Arhaus (NASDAQ:ARHS) fell 9.1% in the morning session after Jefferies analyst Jonathan Matuszewski downgraded the stock's rating from Buy to Hold and lowered the price target from $22 to $16. The analyst cited multiple concerns, including "slowing site traffic growth, falling e-commerce conversion, and a growing percentage of browsing activity tied to sale SKUs." The analyst also highlighted worries related to the housing market, adding, "As investors increasingly embrace a view of persistently stubborn housing turnover into 1H'25, we believe stocks with rich margin expansion will outperform, and we now have less conviction that ARHS will check that box." The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Arhaus? Access our full analysis report here, it's free. What is the market telling us: Arhaus's shares are very volatile and over the last year have had 20 moves greater than 5%. In context of that, today's move is indicating the market considers this news meaningful but not something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 4 months ago, when the stock gained 18.2% on the news that the company reported fourth quarter results that blew past analysts' operating income and EPS forecasts. Its revenue also outperformed Wall Street's estimates. Those two beats were driven by better-than-expected same-store sales performance (6.8% decline compared to an estimated 10.4% decline). Given the strong quarter, management shared upbeat revenue and EBITDA guidance for the full year 2024, easily topping analysts' estimates. Because its free cash flow for the full year 2023 beat its internal projections, Arhaus declared a special, one-time cash dividend of $0.50 per share - this represents a ~4% yield on the current share price. Overall, this quarter's results seemed fairly positive, and shareholders should feel optimistic. Arhaus is up 28% since the beginning of the year, but at $14.93 per share it is still trading 24.1% below its 52-week high of $19.68 from June 2024. Investors who bought $1,000 worth of Arhaus's shares at the IPO in November 2021 would now be looking at an investment worth $1,167. Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefitting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Why Arhaus (ARHS) Shares Are Getting Obliterated Today
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...